Advanced in Demodicidosis

Dr. Joel Schlessinger

Dermatology
Skin Specialists P C.
2802 Oak View Dr, 
Omaha, NE 

Advanced in Demodicidosis
Skin Specialists P C.
2802 Oak View Dr, 
Omaha, NE 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joel Schlessinger is a Dermatologist in Omaha, Nebraska. Dr. Schlessinger is rated as an Advanced provider by MediFind in the treatment of Demodicidosis. His top areas of expertise are Impetigo, Candida Infection of the Skin, Rosacea, and Familial Chronic Mucocutaneous Candidiasis.

His clinical research consists of co-authoring 45 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in NE
Hospital Affiliations
The Nebraska Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avera Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
MVP Health
  • EPO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
SelectHealth
  • HMO
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Wellmark
  • HMO
  • POS
View 29 Less Insurance Carriers -

Locations

Skin Specialists P C.
2802 Oak View Dr, Omaha, NE 68144
Call: 402-334-7546

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A Phase I/II, Observer-blind, Randomised, Placebo-controlled Study to Assess Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
A Phase I/II, Observer-blind, Randomised, Placebo-controlled Study to Assess Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
Enrollment Status: Completed
Publish Date: May 08, 2025
Intervention Type: Biological
Study Phase: Phase 2
Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis
Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis
Enrollment Status: Completed
Publish Date: March 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous Neurofibromas
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous Neurofibromas
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Drug
Study Drug: NFX-179
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: August 18, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat
Enrollment Status: Completed
Publish Date: October 20, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

45 Total Publications

Efficacy and Safety of CBL-514 Injection in Reducing Abdominal Subcutaneous Fat: A Randomized, Single-Blind, Placebo-Controlled Phase II Study.
Efficacy and Safety of CBL-514 Injection in Reducing Abdominal Subcutaneous Fat: A Randomized, Single-Blind, Placebo-Controlled Phase II Study.
Journal: Aesthetic surgery journal
Published: March 04, 2025
View All 45 Publications
Similar Doctors
Advanced in Demodicidosis
Dr. Daniel Schlessinger
Dermatology
Advanced in Demodicidosis
Dr. Daniel Schlessinger
Dermatology

Skin Specialists P C.

2802 Oak View Dr, 
Omaha, NE 
 (0.1 miles away)
402-334-7546
Languages Spoken:
English
See accepted insurances

Daniel Schlessinger is a Dermatologist in Omaha, Nebraska. Dr. Schlessinger is rated as an Advanced provider by MediFind in the treatment of Demodicidosis. His top areas of expertise are Candida Infection of the Skin, Impetigo, Basal Cell Skin Cancer, and Familial Chronic Mucocutaneous Candidiasis.

Experienced in Demodicidosis
Dr. Andrew Patterson
Dermatology
Experienced in Demodicidosis
Dr. Andrew Patterson
Dermatology

CHI Health Clinic Dermatology (La Vista)

8248 S 96th St, 
La Vista, NE 
 (5.4 miles away)
402-717-9500
Languages Spoken:
English
See accepted insurances

Andrew Patterson is a Dermatologist in La Vista, Nebraska. Dr. Patterson is rated as an Advanced provider by MediFind in the treatment of Demodicidosis. His top areas of expertise are Acne, Atopic Dermatitis, Melanoma, and Prurigo Nodularis.

Experienced in Demodicidosis
Dr. Tyler Evans
Dermatology
Experienced in Demodicidosis
Dr. Tyler Evans
Dermatology

CHI Health Clinic Dermatology (70TH & A)

7001 A St Ste 210, 
Lincoln, NE 
 (39.4 miles away)
402-328-6397
Languages Spoken:
English
See accepted insurances

Tyler Evans is a Dermatologist in Lincoln, Nebraska. Dr. Evans is rated as an Advanced provider by MediFind in the treatment of Demodicidosis. His top areas of expertise are Melanoma, Pompholyx Eczema, Actinic Keratosis, and Sunburn.

VIEW MORE DEMODICIDOSIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schlessinger's expertise for a condition
ConditionClose
      • Advanced
      • Actinic Keratosis
        Dr. Schlessinger is
        Advanced
        . Learn about Actinic Keratosis.
        See more Actinic Keratosis experts
      • Atopic Dermatitis
        Dr. Schlessinger is
        Advanced
        . Learn about Atopic Dermatitis.
        See more Atopic Dermatitis experts
      • Candida Infection of the Skin
        Dr. Schlessinger is
        Advanced
        . Learn about Candida Infection of the Skin.
        See more Candida Infection of the Skin experts
      • Comedones
        Dr. Schlessinger is
        Advanced
        . Learn about Comedones.
        See more Comedones experts
      • Demodicidosis
        Dr. Schlessinger is
        Advanced
        . Learn about Demodicidosis.
        See more Demodicidosis experts
      • Familial Atypical Multiple Mole Melanoma Syndrome
        Dr. Schlessinger is
        Advanced
        . Learn about Familial Atypical Multiple Mole Melanoma Syndrome.
        See more Familial Atypical Multiple Mole Melanoma Syndrome experts
      View All 16 Advanced Conditions
      • Experienced
      • Acne
        Dr. Schlessinger is
        Experienced
        . Learn about Acne.
        See more Acne experts
      • Acrogeria, Gottron Type
        Dr. Schlessinger is
        Experienced
        . Learn about Acrogeria, Gottron Type.
        See more Acrogeria, Gottron Type experts
      • Acrokeratoelastoidosis of Costa
        Dr. Schlessinger is
        Experienced
        . Learn about Acrokeratoelastoidosis of Costa.
        See more Acrokeratoelastoidosis of Costa experts
      • Athlete's Foot
        Dr. Schlessinger is
        Experienced
        . Learn about Athlete's Foot.
        See more Athlete's Foot experts
      • Autosomal Recessive Cutis Laxa Type 1
        Dr. Schlessinger is
        Experienced
        . Learn about Autosomal Recessive Cutis Laxa Type 1.
        See more Autosomal Recessive Cutis Laxa Type 1 experts
      • Basal Cell Skin Cancer
        Dr. Schlessinger is
        Experienced
        . Learn about Basal Cell Skin Cancer.
        See more Basal Cell Skin Cancer experts
      View All 82 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        Once you submit your request, MediFind will reach out to the provider’s office to help schedule your appointment. Note that this is not a confirmed booking. You’ll receive a status update via email within 1–2 business days.

        Patient Details

        This information is for the patient who will be seen at the appointment.

            Close

            Returning patient? Use your address on file with the provider.

            Insurance Details

            Please provide information of the primary insurance holder as the practice may require this information to schedule.

            Insurance Provider *
            Insurance ProviderClose

            Appointments Details

            Let’s get more information about your appointment.

                    0 / 1000
                    By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.